Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
<p>Abstract</p> <p>Background</p> <p>The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during...
Main Authors: | Ryttig Kjeld R, Stray-Pedersen Babill, Larsson Per-Göran, Larsen Stig |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-01-01
|
Series: | BMC Women's Health |
Online Access: | http://www.biomedcentral.com/1472-6874/8/3 |
Similar Items
-
Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial
by: Sampada Bangar, et al.
Published: (2023-04-01) -
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis
by: Harold Marcotte, et al.
Published: (2019-09-01) -
The possibilities of clindamycin and butoconazole containing vaginal cream in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with bacterial vaginosis
by: G S Sergiyenko, et al.
Published: (2018-02-01) -
Distinct Functional Traits of Lactobacilli from Women with Asymptomatic Bacterial Vaginosis and Normal Microbiota
by: Rinku Pramanick, et al.
Published: (2020-12-01) -
Proof of concept study of a novel bioadhesive clindamycin phosphate 2% vaginal gel to treat bacterial vaginosis
by: A. Dupre, et al.
Published: (2020-08-01)